Talazoparib,Enzalutamide,Olaparib,abiraterone,Niraparib,Prednisone
Pfizer,Astellas,Merck,AstraZeneca,Janssen
['crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
hrr mutated 1l mcrpc trials: -balance between side effects and potential benefit depends on hrr status. -benefit in pfs # benefit in os.
nice conclusions by at #gu23 #sanfrancisco 
Jefe de Servicio de Oncología Médica. Hospital Universitario Lucus Augusti, HULA. Grupo de Investigación Oncológica Traslacional, GIOT HULA. Cuenta personal